These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 17059445

  • 21. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.
    Kolomeyer AM, Ragam A, Shah K, Jachens AW, Tu Y, Chu DS.
    Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
    Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR.
    J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766
    [Abstract] [Full Text] [Related]

  • 23. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W, Reinisch W, Moser G, Gangl A, Vogelsang H.
    Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
    [Abstract] [Full Text] [Related]

  • 24. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.
    Brill AK, Ott SR, Geiser T.
    Respiration; 2013 Mar; 86(5):376-83. PubMed ID: 23295253
    [Abstract] [Full Text] [Related]

  • 25. Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy.
    Majithia V, Harisdangkul V.
    Rheumatology (Oxford); 2005 Mar; 44(3):386-9. PubMed ID: 15572389
    [Abstract] [Full Text] [Related]

  • 26. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174
    [Abstract] [Full Text] [Related]

  • 27. Candida Esophagitis Associated With Mycophenolate Mofetil Treatment of Atopic Dermatitis.
    Kurayev A, Gottlieb AB.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1267-1269. PubMed ID: 27741346
    [Abstract] [Full Text] [Related]

  • 28. Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis.
    Edge JC, Outland JD, Dempsey JR, Callen JP.
    Arch Dermatol; 2006 Jan 01; 142(1):65-9. PubMed ID: 16415388
    [Abstract] [Full Text] [Related]

  • 29. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
    Koukoulaki M, Jayne DR.
    Nephron Clin Pract; 2006 Jan 01; 102(3-4):c100-7. PubMed ID: 16286784
    [Abstract] [Full Text] [Related]

  • 30. Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease.
    Boulos D, Ngian GS, Rajadurai A, Elford K, Stevens W, Proudman S, Owen C, Roddy J, Nikpour M, Youssef P, Hill C, Sahhar J.
    Int J Rheum Dis; 2017 Apr 01; 20(4):481-488. PubMed ID: 28337853
    [Abstract] [Full Text] [Related]

  • 31. Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease.
    Choudhary A, Harding SP, Bucknall RC, Pearce IA.
    J Ocul Pharmacol Ther; 2006 Jun 01; 22(3):168-75. PubMed ID: 16808677
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus.
    Gammon B, Hansen C, Costner MI.
    J Am Acad Dermatol; 2011 Oct 01; 65(4):717-721.e2. PubMed ID: 21641078
    [Abstract] [Full Text] [Related]

  • 33. Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil.
    Pisoni CN, Obermoser G, Cuadrado MJ, Sanchez FJ, Karim Y, Sepp NT, Khamashta MA, Hughes GR.
    Clin Exp Rheumatol; 2005 Oct 01; 23(3):393-6. PubMed ID: 15971430
    [Abstract] [Full Text] [Related]

  • 34. Chronic actinic dermatitis treated with mycophenolate mofetil.
    Thomson MA, Stewart DG, Lewis HM.
    Br J Dermatol; 2005 Apr 01; 152(4):784-6. PubMed ID: 15840115
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
    Grundmann-Kollmann M, Mooser G, Schraeder P, Zollner T, Kaskel P, Ochsendorf F, Boehncke WH, Kerscher M, Kaufmann R, Peter RU.
    J Am Acad Dermatol; 2000 May 01; 42(5 Pt 1):835-7. PubMed ID: 10775866
    [Abstract] [Full Text] [Related]

  • 37. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 May 01; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 38. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
    Pediatr Int; 2007 Dec 01; 49(6):933-7. PubMed ID: 18045300
    [Abstract] [Full Text] [Related]

  • 39. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.
    Androdias G, Maillet D, Marignier R, Pinède L, Confavreux C, Broussolle C, Vukusic S, Sève P.
    Neurology; 2011 Mar 29; 76(13):1168-72. PubMed ID: 21444902
    [Abstract] [Full Text] [Related]

  • 40. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
    Chatur N, Ramji A, Bain VG, Ma MM, Marotta PJ, Ghent CN, Lilly LB, Heathcote EJ, Deschenes M, Lee SS, Steinbrecher UP, Yoshida EM.
    Liver Int; 2005 Aug 29; 25(4):723-7. PubMed ID: 15998421
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.